Feedback / Questions
ART6043 - Artios Pharma
Undisclosed DDRi-ADC - Artios Pharma
alnodesertib (ART0380) - Artios Pharma
https://www.artios.com/press-release/artios-announces-oversubscribed-115-million-series-d-financing-to-accelerate-clinical-programs-in-indications-of-high-unmet-need/
Nov 17, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next